Article Information
History
- September 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Donald C. Vinh, MD*,1,2,†,
- Jean-Philippe Gouin, PhD*,3,4,
- Diana Cruz-Santiago, MD3,5,
- Michelle Canac-Marquis, MPH1,
- Stéphane Bernier1, MSc,
- Florian Bobeuf, PhD3,
- Avik Sengupta, MD1,
- Jean-Philippe Brassard, BSc1,
- Alyssa Guerra, B.Sc.1,
- Robert Dziarmaga, M.Sc.1,
- Anna Perez, BSc1,
- Yichun Sun, B.Sc.1,
- Yongbiao Li, MD1,
- Lucie Roussel, PhD1,
- Mélanie J. Langelier, MSc(N)1,
- Danbing Ke, MD, PhD9,
- Corey Arnold, PhD6,
- Martin Pelchat, PhD6,7,
- Marc-André Langlois, PhD6,7,
- Timothy G. Evans, MD8,
- Xun Zhang, PhD10,
- Bruce D. Mazer, MD9,11 and
- on behalf of the COVID-19 Immunity Task Force and UNCoVER Investigators
- 1Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montreal, Canada
- 2Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Canada
- 3Centre de recherche de l’Institut de gériatrie de Montréal, Montréal, Canada
- 4Department of Psychology, Faculty of Arts and Sciences, Concordia University, Montreal, Canada
- 5Département de médecine de famille et médecine urgence, Université de Montréal, Montréal, Canada
- 6Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
- 7uOttawa Center for Infection, Immunity and Inflammation (CI3), Ottawa, ON, Canada
- 8School of Population and Global Health, McGill University
- 9Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montreal, Canada
- 10Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, QC, Canada
- 11Division of Allergy, Immunology, and Dermatology, Department of Pediatrics, Montreal Children’s Hospital, Montreal, Quebec, Canada
- ↵†Corresponding author: Donald C. Vinh, MD, FRCP(C), FCIS, Section head, Immunocompromised Host clinical program, Director, Centre of Excellence for Genetic Research in Infection and Immunity, Director, MUHC COVID Biobank, Associate Professor, FRQS Clinician-Scientist, Dept of Medicine (Division of Infectious Diseases; Division of Allergy & Clinical Immunology), Dept of Medical Microbiology; Dept of Human Genetics, McGill University Health Centre - Research Institute, 1001 Decarie Blvd; Block E; Rm EM3-3230 (Mail Drop: EM3-3211) Montreal, Quebec, Canada H4A 3J1, 514-934-1934 ext.42419. email: donald.vinh{at}mcgill.ca
↵* These authors contributed equally to the manuscript.
Posted September 21, 2021.
Real-world serologic responses to Extended-interval and Heterologous COVID-19 mRNA vaccination in Frail Elderly - Interim report from a prospective observational cohort study
